[Asia Economy Reporter Jang Hyowon] In the first week of this month (July), Lunit will conduct a demand forecast targeting institutional investors. Yeongchang Chemical and HPSP are preparing for general subscription.



◆Lunit= Lunit, established in 2013, is a medical AI company whose flagship products include the AI image analysis solution for cancer diagnosis 'Lunit INSIGHT' and the AI biomarker platform for cancer treatment 'Lunit SCOPE.' Lunit's core competitiveness lies in its artificial intelligence (AI) technology. It received AA ratings from all evaluation agencies in the technical evaluation for KOSDAQ technology special listing.


The total number of shares offered is 1,214,300, with an expected public offering price per share of 44,000 to 49,000 KRW. Through this offering, approximately 53.4 billion KRW (based on the lower end of the price band) will be raised. NH Investment & Securities is the lead underwriter. Lunit plans to conduct a demand forecast for institutional investors on July 7-8 to finalize the public offering price, followed by a general subscription on July 12-13, aiming for a listing within July.



◆Yeongchang Chemical= Yeongchang Chemical's public offering price was finalized at the upper end of the desired price band, 18,600 KRW. A total of 1,702 domestic and international institutions participated in the demand forecast, recording a competition rate of 1,616 to 1. Among the participating institutions, 99.3% offered prices at or above the upper end of the price band (including those who did not specify a price), and 60.3% of them offered prices exceeding the upper limit.


The total number of shares offered is 2.4 million, with a total public offering amount of approximately 44.6 billion KRW based on the finalized price. Through the issuance of new shares (83.3%), 37.2 billion KRW will be raised. The general investor subscription will be held over two days on July 4-5. The company plans to list on the KOSDAQ market in mid-July. Hana Securities is the lead underwriter.


Founded in 2001, Yeongchang Chemical is a specialized company in the development and production of chemical materials supplied to the semiconductor, display, and eco-friendly energy industries. Its main products include photoresist, organic hard mask (HT-SOC), slurry, rinsing solution, developer, etchant, and stripper.


◆HPSP= HPSP conducted a demand forecast for institutional investors on June 29-30. The desired public offering price range is 23,000 to 25,000 KRW. The total number of shares offered is 3 million. After finalizing the public offering price through the demand forecast, general subscription is planned for July 6-7. NH Investment & Securities is the lead underwriter.


Established in 2017, HPSP has been primarily engaged in the development and supply of equipment related to hydrogen heat treatment processes in semiconductor front-end processes. The high-pressure heat treatment process electrically passivates interface defects on semiconductor surfaces or junctions to enhance stability. This area demands advanced technology in line with the technological sophistication toward 3D architecture and the increasingly precise semiconductor process development trends.





This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing